Antibody-Based Biologics and Their Promise to Combat Staphylococcus aureus Infections

This publication has 73 references indexed in Scilit:

• Staphylococcus aureus α-Toxin: Nearly a Century of Intrigue
  Toxins, 2013
• Staphylococcus aureus Elaborates Leukocidin AB To Mediate Escape from within Human Neutrophils
  Infection and Immunity, 2013
• Protein A-Specific Monoclonal Antibodies and Prevention of Staphylococcus aureus Disease in Mice
  Infection and Immunity, 2012
• Heavy chain-only antibodies and tetravalent bispecific antibody neutralizing Staphylococcus aureus leukotoxins
  Proceedings of the National Academy of Sciences, 2011
• Methicillin-Susceptible Staphylococcus aureus Endocarditis Isolates Are Associated With Clonal Complex 30 Genotype and a Distinct Repertoire of Enterotoxins and Adhesins
  The Journal of Infectious Diseases, 2011
• Targeting of Alpha‐Hemolysin by Active or Passive Immunization Decreases Severity of USA300 Skin Infection in a Mouse Model
  The Journal of Infectious Diseases, 2010
• Phase 1/2 Double-Blind, Placebo-Controlled, Dose Escalation, Safety, and Pharmacokinetic Study of Pagibaximab (BSYX-A110), an Antistaphylococcal Monoclonal Antibody for the Prevention of Staphylococcal Bloodstream Infections, in Very-Low-Birth-Weight Neonates
  Antimicrobial Agents and Chemotherapy, 2009
• Vaccine protection againstStaphylococcus aureuspneumonia
  The Journal of Experimental Medicine, 2008
• Phase II, Randomized, Double-Blind, Multicenter Study Comparing the Safety and Pharmacokinetics of Tefibazumab to Placebo for Treatment of Staphylococcus aureus Bacteremia
  Antimicrobial Agents and Chemotherapy, 2006
• A Novel Staphylococcus aureus Vaccine: Iron Surface Determinant B Induces Rapid Antibody Responses in Rhesus Macaques and Specific Increased Survival in a Murine S. aureus Sepsis Model
  Infection and Immunity, 2006